TY - JOUR
T1 - Novel structural motifs consisting of chiral thiazolines
T2 - Synthesis, molecular recognition, and anticancer activity
AU - Han, Fu She
AU - Osajima, Hiroyuki
AU - Cheung, Mui
AU - Tokuyama, Hidetoshi
AU - Fukuyama, Tohru
PY - 2007
Y1 - 2007
N2 - The facile synthesis of linear and cyclic chiral oligo(4-α/β- methyl)-thiazolines is described. Linear oligothiazolines have been efficiently synthesized by the iterative formation of thiazoline rings and two-directional block condensation. The construction of 24- to 36-membered cyclic oligothiazolines was achieved through the head-to-tail cyclo-oligomerization of doubly deprotected linear fragments. Studies of the interactions of both the linear and cyclic oligomers with chiral compounds revealed that cyclic oligomers displayed a strong binding affinity towards mandelic acid, whereas linear oligomers showed a poor affinity. Linear oligomers have been proven to inhibit the cell growth of the cancer cell lines HPAC, PC-3, and HCT-116. Studies of the structure-activity relationships showed that the IC50 values are clearly dependent on both the length and the terminal functionalities of the linear oligomers. Longer derivatives showed more potent activity (e.g., hexi- and octithiazolines exhibit IC50 < 1 μM) against all three cancer cell lines. In sharp contrast, cyclic oligomers were inactive to all three cell lines.
AB - The facile synthesis of linear and cyclic chiral oligo(4-α/β- methyl)-thiazolines is described. Linear oligothiazolines have been efficiently synthesized by the iterative formation of thiazoline rings and two-directional block condensation. The construction of 24- to 36-membered cyclic oligothiazolines was achieved through the head-to-tail cyclo-oligomerization of doubly deprotected linear fragments. Studies of the interactions of both the linear and cyclic oligomers with chiral compounds revealed that cyclic oligomers displayed a strong binding affinity towards mandelic acid, whereas linear oligomers showed a poor affinity. Linear oligomers have been proven to inhibit the cell growth of the cancer cell lines HPAC, PC-3, and HCT-116. Studies of the structure-activity relationships showed that the IC50 values are clearly dependent on both the length and the terminal functionalities of the linear oligomers. Longer derivatives showed more potent activity (e.g., hexi- and octithiazolines exhibit IC50 < 1 μM) against all three cancer cell lines. In sharp contrast, cyclic oligomers were inactive to all three cell lines.
KW - Anticancer agents
KW - Macrocycles
KW - Molecular recognition
KW - Oligomerization
KW - Thiazolines
UR - http://www.scopus.com/inward/record.url?scp=34250668246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250668246&partnerID=8YFLogxK
U2 - 10.1002/chem.200601446
DO - 10.1002/chem.200601446
M3 - Article
C2 - 17285652
AN - SCOPUS:34250668246
SN - 0947-6539
VL - 13
SP - 3026
EP - 3038
JO - Chemistry - A European Journal
JF - Chemistry - A European Journal
IS - 11
ER -